Dear Colleague,
Data from several landmark clinical trials is likely to have changed the conventional approach to initiating and managing RRT for AKI in the ICU. In the ESICM endorsed survey we wish to quantify the impact of new scientific knowledge and clinical experience during and after the pandemic on our daily clinical practice in provision of RRT in the ICU.
Please answer the following short questionnaire in relation to your clinical practice and your Centre’s activity in the field of AKI and renal replacement therapies during the last year. All questions concerning current practice are related to experience/activities in 2023 and, when requested, please describe the behavioural changes compared to 2018 (5 years previously).
We thank you for the attention and time you want to dedicate to this initiative.
Best regards,
Silvia De Rosa
Bairbre McNicholas
John Prowle